Andexxa--an antidote for apixaban and rivaroxaban.

Subjects

Subjects :

Administration, Oral
Dose-Response Relationship, Drug
Drug Approval
Factor Xa economics
Factor Xa pharmacology
Humans
Pyrazoles adverse effects
Pyridones adverse effects
Randomized Controlled Trials as Topic
Recombinant Proteins economics
Recombinant Proteins pharmacology
Rivaroxaban adverse effects
United States
United States Food and Drug Administration
Anticoagulants adverse effects
Antidotes therapeutic use
Factor Xa therapeutic use
Hemorrhage chemically induced
Hemorrhage drug therapy
Recombinant Proteins therapeutic use

Details

Language :

English

ISSN :

1523-2859

Volume :

60

Issue :

1549

Database :

MEDLINE

Journal :

The Medical letter on drugs and therapeutics

Publication Type :

Academic Journal

Accession number :

29913471